{
  "DOI": "10.1038/s41431-020-00783-9",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-020-00783-9",
  "alternative-id": [
    "783"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "4 July 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "19 October 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "29 October 2020"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "16 December 2020"
    },
    {
      "group": {
        "label": "Compliance with ethical standards",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that they have no conflict of interest."
    },
    {
      "group": {
        "label": "Ethical approval",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "HRA REC 227795/17CAG0183 approved."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0003-4383-6038",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Martin",
      "given": "Antony P.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Downing",
      "given": "Jennifer",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-3023-8189",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Collins",
      "given": "Brendan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Godman",
      "given": "Brian",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Alfirevic",
      "given": "Ana",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Greenhalgh",
      "given": "Karen Lynn",
      "sequence": "additional"
    },
    {
      "ORCID": "http://orcid.org/0000-0002-7534-7266",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Pirmohamed",
      "given": "Munir",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2020,
        12,
        16
      ]
    ],
    "date-time": "2020-12-16T14:05:41Z",
    "timestamp": 1608127541000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        20
      ]
    ],
    "date-time": "2023-05-20T21:01:17Z",
    "timestamp": 1684616477000
  },
  "funder": [
    {
      "name": "National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care North West Coast (NIHR CLAHRC NWC)."
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        1
      ]
    ],
    "date-time": "2023-09-01T23:29:08Z",
    "timestamp": 1693610948656
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2020,
        12,
        16
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2021,
          4
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            12,
            16
          ]
        ],
        "date-time": "2020-12-16T00:00:00Z",
        "timestamp": 1608076800000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2020,
            12,
            16
          ]
        ],
        "date-time": "2020-12-16T00:00:00Z",
        "timestamp": 1608076800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/s41431-020-00783-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-020-00783-9",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/s41431-020-00783-9.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "699-708",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2020,
        12,
        16
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2020,
        12,
        16
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        4
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.ygyno.2012.12.016",
      "author": "G Chornokur",
      "doi-asserted-by": "publisher",
      "first-page": "258",
      "journal-title": "Gynecol Oncol",
      "key": "783_CR1",
      "unstructured": "Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM. Global ovarian cancer health disparities. Gynecol Oncol. 2013;129:258–64. https://doi.org/10.1016/j.ygyno.2012.12.016.",
      "volume": "129",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.jacr.2016.10.003",
      "author": "ET Rosenthal",
      "doi-asserted-by": "publisher",
      "first-page": "561",
      "journal-title": "J Am Coll Radiol",
      "key": "783_CR2",
      "unstructured": "Rosenthal ET, Evans B, Kidd J, Brown K, Gorringe H, van Orman M, et al. Increased identification of candidates for high-risk breast cancer screening through expanded genetic testing. J Am Coll Radiol. 2017;14:561–8. https://doi.org/10.1016/j.jacr.2016.10.003.",
      "volume": "14",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2012.43.1882",
      "author": "E Castro",
      "doi-asserted-by": "publisher",
      "first-page": "1748",
      "journal-title": "J Clin Oncol",
      "key": "783_CR3",
      "unstructured": "Castro E, Goh C, Olmos D, Saunders E, Leongamornlert D, Tymrakiewicz M, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol. 2013;31:1748–57. https://doi.org/10.1200/JCO.2012.43.1882.",
      "volume": "31",
      "year": "2013"
    },
    {
      "DOI": "10.1186/s13053-015-0038-x",
      "author": "H Cavanagh",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Hered Cancer Clin Pract",
      "key": "783_CR4",
      "unstructured": "Cavanagh H, Rogers KMA. The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers. Hered Cancer Clin Pract. 2015;13:1–7. https://doi.org/10.1186/s13053-015-0038-x.",
      "volume": "13",
      "year": "2015"
    },
    {
      "DOI": "10.1038/ejhg.2016.93",
      "author": "D Stoppa-Lyonnet",
      "doi-asserted-by": "publisher",
      "first-page": "S3",
      "journal-title": "Eur J Hum Genet",
      "key": "783_CR5",
      "unstructured": "Stoppa-Lyonnet D. The biological effects and clinical implications of BRCA mutations: Where do we go from here?. Eur J Hum Genet. 2016;24:S3–9. https://doi.org/10.1038/ejhg.2016.93.",
      "volume": "24",
      "year": "2016"
    },
    {
      "DOI": "10.1056/NEJMra1503523",
      "author": "LC Hartmann",
      "doi-asserted-by": "publisher",
      "first-page": "454",
      "journal-title": "N Engl J Med",
      "key": "783_CR6",
      "unstructured": "Hartmann LC, Lindor NM. The role of risk-reducing surgery in hereditary breast and ovarian cancer. N Engl J Med. 2016;374:454–68. https://doi.org/10.1056/NEJMra1503523.",
      "volume": "374",
      "year": "2016"
    },
    {
      "DOI": "10.1093/annonc/mdw327",
      "author": "S Paluch-Shimon",
      "doi-asserted-by": "publisher",
      "first-page": "v103",
      "journal-title": "Ann Oncol",
      "key": "783_CR7",
      "unstructured": "Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, et al. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO clinical practice guidelines for cancer prevention and screening. Ann Oncol. 2016;27:v103–10. https://doi.org/10.1093/annonc/mdw327.",
      "volume": "27",
      "year": "2016"
    },
    {
      "key": "783_CR8",
      "unstructured": "National Breast Cancer Foundation Inc. Genetic testing for breast cancer. https://www.nationalbreastcancer.org/genetic-testing-for-breast-cancer. [Accessed 10/12/2020]."
    },
    {
      "DOI": "10.1200/JCO.2015.60.8596",
      "author": "MB Yurgelun",
      "doi-asserted-by": "publisher",
      "first-page": "3092",
      "journal-title": "J Clin Oncol",
      "key": "783_CR9",
      "unstructured": "Yurgelun MB, Hiller E, Garber JE. Population-wide screening for germline BRCA1 and BRCA2 mutations: Too much of a good thing?. J Clin Oncol. 2015;33:3092–5. https://doi.org/10.1200/JCO.2015.60.8596.",
      "volume": "33",
      "year": "2015"
    },
    {
      "DOI": "10.1007/s10689",
      "author": "SM Mahon",
      "doi-asserted-by": "publisher",
      "first-page": "99",
      "journal-title": "Oncol Nurs Forum",
      "key": "783_CR10",
      "unstructured": "Mahon SM. Cancer risks for men with BRCA1/2 mutations. Oncol Nurs Forum. 2014;41:99–101. https://doi.org/10.1007/s10689.",
      "volume": "41",
      "year": "2014"
    },
    {
      "DOI": "10.1016/j.pec.2017.07.015",
      "author": "EA Rauscher",
      "doi-asserted-by": "publisher",
      "first-page": "340",
      "journal-title": "Patient Educ Couns",
      "key": "783_CR11",
      "unstructured": "Rauscher EA, Dean M. “I’ve just never gotten around to doing it”: men’s approaches to managing BRCA-related cancer risks. Patient Educ Couns. 2018;101:340–5.",
      "volume": "101",
      "year": "2018"
    },
    {
      "key": "783_CR12",
      "unstructured": "NICE. Familial breast cancer: the classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. Clinical Guideline 164. London; 2013. http://guidance.nice.org.uk/CG164."
    },
    {
      "DOI": "10.1136/bmj.322.7293.1052",
      "author": "JP Evans",
      "doi-asserted-by": "publisher",
      "first-page": "1052",
      "journal-title": "BMJ.",
      "key": "783_CR13",
      "unstructured": "Evans JP, Skrzynia C, Burke W. The complexities of predictive genetic testing. BMJ. 2001;322:1052–6. https://doi.org/10.1136/bmj.322.7293.1052.",
      "volume": "322",
      "year": "2001"
    },
    {
      "DOI": "10.1073/pnas.1415979111",
      "author": "E Gabai-Kapara",
      "doi-asserted-by": "publisher",
      "first-page": "14205",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "783_CR14",
      "unstructured": "Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, et al. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci USA. 2014;111:14205–10. https://doi.org/10.1073/pnas.1415979111.",
      "volume": "111",
      "year": "2014"
    },
    {
      "DOI": "10.1007/s12687-018-0370-8",
      "doi-asserted-by": "publisher",
      "key": "783_CR15",
      "unstructured": "Sayani A. Inequities in genetic testing for hereditary breast cancer: implications for public health practice. J Community Genet. 2018;1–5. https://doi.org/10.1007/s12687-018-0370-8."
    },
    {
      "DOI": "10.1007/s10689-008-9184-x",
      "author": "SM Holloway",
      "doi-asserted-by": "publisher",
      "first-page": "259",
      "journal-title": "Fam Cancer",
      "key": "783_CR16",
      "unstructured": "Holloway SM, Bernhard B, Campbell H, Cetnarskyj R, Lam WWK. Inequality of use of cancer genetics services by members of breast, ovarian and colorectal cancer families in South East Scotland. Fam Cancer. 2008;7:259–64. https://doi.org/10.1007/s10689-008-9184-x.",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1007/s10549-015-3374-7",
      "author": "D Cragun",
      "doi-asserted-by": "publisher",
      "first-page": "169",
      "journal-title": "Breast Cancer Res Treat",
      "key": "783_CR17",
      "unstructured": "Cragun D, Bonner D, Kim J, Akbari MR, Narod SA, Gomez-Fuego A, et al. Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer. Breast Cancer Res Treat. 2015;151:169–76. https://doi.org/10.1007/s10549-015-3374-7.",
      "volume": "151",
      "year": "2015"
    },
    {
      "DOI": "10.1002/cncr.28966",
      "author": "RA Yusuf",
      "doi-asserted-by": "publisher",
      "first-page": "243",
      "journal-title": "Cancer.",
      "key": "783_CR18",
      "unstructured": "Yusuf RA, Rogith D, Hovick SRA, Peterson SK, Burton-Chase AM, Fellman BM, et al. Attitudes toward molecular testing for personalized cancer therapy. Cancer. 2015;121:243–50. https://doi.org/10.1002/cncr.28966.",
      "volume": "121",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.amepre.2014.01.002",
      "author": "PL Mai",
      "doi-asserted-by": "publisher",
      "first-page": "440",
      "journal-title": "Am J Prev Med",
      "key": "783_CR19",
      "unstructured": "Mai PL, Vadaparampil ST, Breen N, McNeel TS, Wideroff L, Graubard BI. Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 national health interview surveys. Am J Prev Med. 2014;46:440–8. https://doi.org/10.1016/j.amepre.2014.01.002.",
      "volume": "46",
      "year": "2014"
    },
    {
      "DOI": "10.1155/2012/309109",
      "author": "LJ Finney Rutten",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "J Cancer Epidemiol",
      "key": "783_CR20",
      "unstructured": "Finney Rutten LJ, Gollust SE, Naveed S, Moser RP. Increasing public awareness of direct-to-consumer genetic tests: Health care access, internet use, and population density correlates. J Cancer Epidemiol. 2012;2012:6–10. https://doi.org/10.1155/2012/309109.",
      "volume": "2012",
      "year": "2012"
    },
    {
      "DOI": "10.1159/000111638",
      "author": "JE Heck",
      "doi-asserted-by": "publisher",
      "first-page": "36",
      "journal-title": "Community Genet",
      "key": "783_CR21",
      "unstructured": "Heck JE, Franco R, Jurkowski JM, Sheinfeld Gorin S. Awareness of genetic testing for cancer among United States hispanics: the role of acculturation. Community Genet. 2008;11:36–42. https://doi.org/10.1159/000111638.",
      "volume": "11",
      "year": "2008"
    },
    {
      "DOI": "10.1038/gim.2014.125",
      "author": "M Butrick",
      "doi-asserted-by": "publisher",
      "first-page": "467",
      "journal-title": "Genet Med",
      "key": "783_CR22",
      "unstructured": "Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, et al. Uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med. 2015;17:467–75. https://doi.org/10.1038/gim.2014.125.",
      "volume": "17",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.amepre.2009.07.021",
      "author": "J Pagan",
      "doi-asserted-by": "publisher",
      "first-page": "524",
      "journal-title": "Am J Prev Med",
      "key": "783_CR23",
      "unstructured": "Pagan J, Su D, Li L, Armstrong K, Asch DA. Racial and ethnic disparities in awareness of genetic testing for cancer risk. Am J Prev Med. 2009;37:524–30. https://doi.org/10.1016/j.amepre.2009.07.021.",
      "volume": "37",
      "year": "2009"
    },
    {
      "DOI": "10.1159/000164684",
      "author": "C Molster",
      "doi-asserted-by": "publisher",
      "first-page": "84",
      "journal-title": "Public Health Genom",
      "key": "783_CR24",
      "unstructured": "Molster C, Charles T, Samanek A, O’Leary P. Australian study on public knowledge of human genetics and health. Public Health Genom. 2009;12:84–91. https://doi.org/10.1159/000164684.",
      "volume": "12",
      "year": "2009"
    },
    {
      "DOI": "10.1530/ERC-14-0411",
      "author": "SB Haga",
      "doi-asserted-by": "publisher",
      "first-page": "197",
      "journal-title": "Pharmacogenomics J",
      "key": "783_CR25",
      "unstructured": "Haga SB, O’Daniel JM, Tindall GM, Lipkus IR, Agans R. Survey of U.S. public attitudes towards pharmacogenetic testing. Pharmacogenomics J. 2012;12:197–204. https://doi.org/10.1530/ERC-14-0411.",
      "volume": "12",
      "year": "2012"
    },
    {
      "DOI": "10.1093/heapro/6.3.217",
      "author": "M Whitehead",
      "doi-asserted-by": "publisher",
      "first-page": "217",
      "journal-title": "Health Promot Int",
      "key": "783_CR26",
      "unstructured": "Whitehead M. The concepts and principles of equity and health. Health Promot Int. 1991;6:217–28. https://doi.org/10.1093/heapro/6.3.217.",
      "volume": "6",
      "year": "1991"
    },
    {
      "key": "783_CR27",
      "unstructured": "Department for Communities and Local Government. The english index of multiple deprivation (IMD) 2015—guidance. 2015. https://www.gov.uk/government/statistics/english-indices-ofdeprivation-2015. Accessed 2 May 2020."
    },
    {
      "DOI": "10.1007/b97377",
      "doi-asserted-by": "crossref",
      "key": "783_CR28",
      "unstructured": "Klein J, Moeschberger M. Survival analysis: techniques for censored and truncated data. 2nd ed. New York: Springer; 2003."
    },
    {
      "DOI": "10.1002/sim.4780141510",
      "author": "KR Hess",
      "doi-asserted-by": "publisher",
      "first-page": "1707",
      "journal-title": "Stat Med",
      "key": "783_CR29",
      "unstructured": "Hess KR. Graphical methods for assessing violations of the proportional hazards assumption in cox regression. Stat Med. 1995;14:1707–23. https://doi.org/10.1002/sim.4780141510.",
      "volume": "14",
      "year": "1995"
    },
    {
      "DOI": "10.1136/bmj.b2393",
      "author": "JAC Sterne",
      "doi-asserted-by": "publisher",
      "first-page": "b2393.",
      "journal-title": "BMJ.",
      "key": "783_CR30",
      "unstructured": "Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. https://doi.org/10.1136/bmj.b2393.",
      "volume": "338",
      "year": "2009"
    },
    {
      "DOI": "10.1038/gim.2016.29",
      "author": "E D’Andrea",
      "doi-asserted-by": "publisher",
      "first-page": "1171",
      "journal-title": "Genet Med",
      "key": "783_CR31",
      "unstructured": "D’Andrea E, Marzuillo C, De Vito C, Di Marco M, Pitini E, Vacchio MR, et al. Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations. Genet Med. 2016;18:1171–80. https://doi.org/10.1038/gim.2016.29.",
      "volume": "18",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.ajog.2013.01.026",
      "author": "K Singh",
      "doi-asserted-by": "publisher",
      "first-page": "329.e1",
      "journal-title": "Am J Obstet Gynecol",
      "key": "783_CR32",
      "unstructured": "Singh K, Lester J, Karlan B, Bresee C, Geva T, Gordon O. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Am J Obstet Gynecol. 2013;208:329.e1–6. https://doi.org/10.1016/j.ajog.2013.01.026.",
      "volume": "208",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41416-019-0446-1",
      "author": "K Metcalfe",
      "doi-asserted-by": "publisher",
      "first-page": "15",
      "journal-title": "Br J Cancer",
      "key": "783_CR33",
      "unstructured": "Metcalfe K, Eisen A, Senter L, Risch HA, Rosen B, Murphy J, et al. International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. Br J Cancer. 2019;121:15–21. https://doi.org/10.1038/s41416-019-0446-1.",
      "volume": "121",
      "year": "2019"
    },
    {
      "DOI": "10.1038/ejhg.2013.143",
      "author": "R MacLeod",
      "doi-asserted-by": "publisher",
      "first-page": "396",
      "journal-title": "Eur J Hum Genet",
      "key": "783_CR34",
      "unstructured": "MacLeod R, Beach A, Henriques S, Knopp J, Nelson K, Kerzin-Storrar L. Experiences of predictive testing in young people at risk of Huntington’s disease, familial cardiomyopathy or hereditary breast and ovarian cancer. Eur J Hum Genet. 2013;22:396. https://doi.org/10.1038/ejhg.2013.143.",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10897-015-9845-5",
      "author": "K Brunstrom",
      "doi-asserted-by": "publisher",
      "first-page": "90",
      "journal-title": "J Genet Couns",
      "key": "783_CR35",
      "unstructured": "Brunstrom K, Murray A, McAllister M. Experiences of women who underwent predictive BRCA 1/2 mutation testing before the age of 30. J Genet Couns. 2016;25:90–100. https://doi.org/10.1007/s10897-015-9845-5.",
      "volume": "25",
      "year": "2016"
    },
    {
      "DOI": "10.1038/gim.2017.52",
      "author": "E Healey",
      "doi-asserted-by": "publisher",
      "first-page": "1323",
      "journal-title": "Genet Med",
      "key": "783_CR36",
      "unstructured": "Healey E, Taylor N, Greening S, Wakefield CE, Warwick L, Williams R, et al. Quantifying family dissemination and identifying barriers to communication of risk information in Australian BRCA families. Genet Med. 2017;19:1323–31. https://doi.org/10.1038/gim.2017.52.",
      "volume": "19",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s10897-013-9592-4",
      "author": "J Fehniger",
      "doi-asserted-by": "publisher",
      "first-page": "603",
      "journal-title": "J Genet Couns",
      "key": "783_CR37",
      "unstructured": "Fehniger J, Lin F, Beattie MS, Joseph G, Kaplan C. Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers. J Genet Couns. 2013;22:603–12. https://doi.org/10.1007/s10897-013-9592-4.",
      "volume": "22",
      "year": "2013"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-10-0325",
      "author": "EL Cheung",
      "doi-asserted-by": "publisher",
      "first-page": "2211",
      "journal-title": "Cancer Epidemiol Biomark Prev",
      "key": "783_CR38",
      "unstructured": "Cheung EL, Olson AD, Yu TM, Han PZ, Beattie MS. Communication of BRCA results and family testing in 1,103 high-risk women. Cancer Epidemiol Biomark Prev. 2010;19:2211–9. https://doi.org/10.1158/1055-9965.EPI-10-0325.",
      "volume": "19",
      "year": "2010"
    },
    {
      "DOI": "10.1038/gim.2018.26",
      "author": "S Lieberman",
      "doi-asserted-by": "publisher",
      "first-page": "1446",
      "journal-title": "Genet Med",
      "key": "783_CR39",
      "unstructured": "Lieberman S, Lahad A, Tomer A, Koka S, BenUziyahu M, Raz A, et al. Familial communication and cascade testing among relatives of BRCA population screening participants. Genet Med. 2018;20:1446–54. https://doi.org/10.1038/gim.2018.26.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10689-018-0089-z",
      "author": "FH Menko",
      "doi-asserted-by": "publisher",
      "first-page": "127",
      "journal-title": "Fam Cancer",
      "key": "783_CR40",
      "unstructured": "Menko FH, ter Stege JA, van der Kolk LE, Jeanson KN, Schats W, Moha DA, et al. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice. Fam Cancer. 2019;18:127–35. https://doi.org/10.1007/s10689-018-0089-z.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s10689-015-9854-4",
      "author": "E Sermijn",
      "doi-asserted-by": "publisher",
      "first-page": "155",
      "journal-title": "Fam Cancer",
      "key": "783_CR41",
      "unstructured": "Sermijn E, Delesie L, Deschepper E, Pauwels I, Bonduelle M, Teugels E, et al. The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safety. Fam Cancer. 2016;15:155–62. https://doi.org/10.1007/s10689-015-9854-4.",
      "volume": "15",
      "year": "2016"
    },
    {
      "DOI": "10.1007/s12687-012-0132-y",
      "author": "L Black",
      "doi-asserted-by": "publisher",
      "first-page": "203",
      "journal-title": "J Community Genet",
      "key": "783_CR42",
      "unstructured": "Black L, McClellan KA, Avard D, Knoppers BM. Intrafamilial disclosure of risk for hereditary breast and ovarian cancer: points to consider. J Community Genet. 2013;4:203–14. https://doi.org/10.1007/s12687-012-0132-y.",
      "volume": "4",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s10897-014-9805-5",
      "author": "R George",
      "doi-asserted-by": "publisher",
      "first-page": "388",
      "journal-title": "J Genet Couns",
      "key": "783_CR43",
      "unstructured": "George R, Kovak K, Cox SL. Aligning policy to promote cascade genetic screening for prevention and early diagnosis of heritable diseases. J Genet Couns. 2015;24:388–99. https://doi.org/10.1007/s10897-014-9805-5.",
      "volume": "24",
      "year": "2015"
    },
    {
      "DOI": "10.1177/0968533217721966",
      "author": "C Mitchell",
      "doi-asserted-by": "publisher",
      "first-page": "158",
      "journal-title": "Med Law Int",
      "key": "783_CR44",
      "unstructured": "Mitchell C, Goodwin D, Ploem C, Bell J, Hennekam R, Wallace S, et al. Exploring the potential duty of care in clinical genomics under UK law. Med Law Int. 2017;17:158–82. https://doi.org/10.1177/0968533217721966.",
      "volume": "17",
      "year": "2017"
    },
    {
      "DOI": "10.1038/gim.2017.257",
      "author": "MA Rothstein",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Genet Med",
      "key": "783_CR45",
      "unstructured": "Rothstein MA. Reconsidering the duty to warn genetically at-risk relatives. Genet Med. 2018;20:285–90. https://doi.org/10.1038/gim.2017.257.",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1007/s10897-017-0164-x",
      "author": "S Dheensa",
      "doi-asserted-by": "publisher",
      "first-page": "689",
      "journal-title": "J Genet Couns",
      "key": "783_CR46",
      "unstructured": "Dheensa S, Lucassen A, Fenwick A. Limitations and pitfalls of using family letters to communicate genetic risk: a qualitative study with patients and healthcare professionals. J Genet Couns. 2018;27:689–701. https://doi.org/10.1007/s10897-017-0164-x.",
      "volume": "27",
      "year": "2018"
    },
    {
      "DOI": "10.1001/jama.2014.17442",
      "author": "M-C King",
      "doi-asserted-by": "publisher",
      "first-page": "525",
      "journal-title": "JAMA.",
      "key": "783_CR47",
      "unstructured": "King M-C, Lahad A, Levy-Lahad E. Proposed shift in screening for breast cancer-reply. JAMA. 2015;313:525–6. https://doi.org/10.1001/jama.2014.17442.",
      "volume": "313",
      "year": "2015"
    },
    {
      "DOI": "10.1001/jama.2014.12483",
      "author": "M-C King",
      "doi-asserted-by": "publisher",
      "first-page": "1091",
      "journal-title": "JAMA.",
      "key": "783_CR48",
      "unstructured": "King M-C, Levy-Lahad E, Lahad A. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award. JAMA. 2014;312:1091–2. https://doi.org/10.1001/jama.2014.12483.",
      "volume": "312",
      "year": "2014"
    }
  ],
  "reference-count": 48,
  "references-count": 48,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-020-00783-9"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Examining the uptake of predictive BRCA testing in the UK; findings and implications"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "29"
}